Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2011

Open Access 01-12-2011 | Original investigation

The interleukin-6 and noradrenaline mediated inflammation-stress feedback mechanism is dysregulated in metabolic syndrome: Effect of exercise

Authors: Leticia Martín-Cordero, Juan J García, Maria D Hinchado, Eduardo Ortega

Published in: Cardiovascular Diabetology | Issue 1/2011

Login to get access

Abstract

Background

Metabolic syndrome (MS) is a metabolic disorder associated with obesity, type-II diabetes, and "low grade inflammation", with the concomitant increased risk of cardiovascular events. Removal of the inflammatory mediator signals is a promising strategy to protect against insulin resistance, obesity, and other problems associated with MS such as cardiovascular disease. The aim of the present investigation was to determine the "inflammatory and stress status" in an experimental model of MS, and to evaluate the effect of a program of habitual exercise and the resulting training-induced adaptation to the effects of a single bout of acute exercise.

Methods

Obese Zucker rats (fa/fa) were used as the experimental model of MS, and lean Zucker rats (Fa/fa) were used for reference values. The habitual exercise (performed by the obese rats) consisted of treadmill running: 5 days/week for 14 weeks, at 35 cm/s for 35 min in the last month. The acute exercise consisted of a single session of 25-35 min at 35 cm/s. Circulating concentrations of IL-6 (a cytokine that regulates the inflammatory and metabolic responses), CRP (a systemic inflammatory marker), and corticosterone (CTC) (the main glucocorticoid in rats) were determined by ELISA, and that of noradrenaline (NA) was determined by HPLC. Glucose was determined by standard methods.

Results

The genetically obese animals showed higher circulating levels of glucose, IL-6, PCR, and NA compared with the control lean animals. The habitual exercise program increased the concentration of IL-6, PCR, NA, and glucose, but decreased that of CTC. Acute exercise increased IL-6, CRP, and NA in the sedentary obese animals, but not in the trained obese animals. CTC was increased after the acute exercise in the trained animals only.

Conclusion

Animals with MS present a dysregulation in the feedback mechanism between IL-6 and NA which can contribute to the systemic low-grade inflammation and/or hyperglycaemia of MS. An inappropriate exercise intensity can worsen this dysregulation, contributing to the metabolic, inflammatory, and stress disorders associated with MS. Habitual exercise (i.e., training) induces a positive adaptation in the response to acute exercise.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hansen BC: The metabolic syndrome X. Ann N Y Acad Sci. 1999, 892: 1-24. 10.1111/j.1749-6632.1999.tb07782.x.CrossRefPubMed Hansen BC: The metabolic syndrome X. Ann N Y Acad Sci. 1999, 892: 1-24. 10.1111/j.1749-6632.1999.tb07782.x.CrossRefPubMed
2.
go back to reference Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2005, 365: 1415-1428. 10.1016/S0140-6736(05)66378-7.CrossRefPubMed Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2005, 365: 1415-1428. 10.1016/S0140-6736(05)66378-7.CrossRefPubMed
3.
go back to reference Zimmet P, George K, Alberti MM, Serrano M: Una nueva definición mundial del síndrome metabólico propuesta por la Federación Internacional de Diabetes: fundamento y resultados. Rev Esp Cardiol. 2005, 58: 1371-1376. 10.1016/S0300-8932(05)74065-3.CrossRefPubMed Zimmet P, George K, Alberti MM, Serrano M: Una nueva definición mundial del síndrome metabólico propuesta por la Federación Internacional de Diabetes: fundamento y resultados. Rev Esp Cardiol. 2005, 58: 1371-1376. 10.1016/S0300-8932(05)74065-3.CrossRefPubMed
4.
go back to reference Das UN: Is metabolic syndrome × an inflammatory condition?. Exp Biol Med. 2002, 227: 989-997. Das UN: Is metabolic syndrome × an inflammatory condition?. Exp Biol Med. 2002, 227: 989-997.
5.
go back to reference Das UN: Metabolic syndrome X: an inflammatory condition?. Curr Hypertens Rep. 2004, 6: 66-73. 10.1007/s11906-004-0014-8.CrossRefPubMed Das UN: Metabolic syndrome X: an inflammatory condition?. Curr Hypertens Rep. 2004, 6: 66-73. 10.1007/s11906-004-0014-8.CrossRefPubMed
7.
go back to reference Petersen AM, Pedersen BK: The anti-inflammatory effect of exercise. J Appl Physiol. 2005, 98: 1154-1162. 10.1152/japplphysiol.00164.2004.CrossRefPubMed Petersen AM, Pedersen BK: The anti-inflammatory effect of exercise. J Appl Physiol. 2005, 98: 1154-1162. 10.1152/japplphysiol.00164.2004.CrossRefPubMed
8.
go back to reference De Lemos ET, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-Pereira P, Silva AS, Teixeira F: Exercise training is associated with improved levels of C-reactive protein and adiponectin in ZDF (type 2) diabetic rats. Med Sci Monit. 2007, 13: 168-174. De Lemos ET, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-Pereira P, Silva AS, Teixeira F: Exercise training is associated with improved levels of C-reactive protein and adiponectin in ZDF (type 2) diabetic rats. Med Sci Monit. 2007, 13: 168-174.
9.
go back to reference Teixeira de Lemos E, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-Pereira P, Correia da Silva G, Teixeira N, Silva AS, Carvalho L, Teixeira F, Das UN: Exercise training decreases proinflammatory profile in Zucker diabetic (type 2) fatty rats. Nutrition. 2009, 25: 330-339. 10.1016/j.nut.2008.08.014.CrossRefPubMed Teixeira de Lemos E, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-Pereira P, Correia da Silva G, Teixeira N, Silva AS, Carvalho L, Teixeira F, Das UN: Exercise training decreases proinflammatory profile in Zucker diabetic (type 2) fatty rats. Nutrition. 2009, 25: 330-339. 10.1016/j.nut.2008.08.014.CrossRefPubMed
10.
go back to reference Martín-Cordero L, García JJ, Hinchado MD, Bote E, Manso R, Ortega E: Habitual physical exercise improves macrophage IL-6 and TNF-α deregulated release in the obese zucker rat model of the metabolic syndrome. Neuroimmunomodulation. 2011, 18: 123-130. 10.1159/000322053.CrossRefPubMed Martín-Cordero L, García JJ, Hinchado MD, Bote E, Manso R, Ortega E: Habitual physical exercise improves macrophage IL-6 and TNF-α deregulated release in the obese zucker rat model of the metabolic syndrome. Neuroimmunomodulation. 2011, 18: 123-130. 10.1159/000322053.CrossRefPubMed
11.
go back to reference Besedovsky HO, Del Rey A: Physiology of psychoneuroimmunology: A personal view. Brain Behav Immun. 2007, 21: 34-44. 10.1016/j.bbi.2006.09.008.CrossRefPubMed Besedovsky HO, Del Rey A: Physiology of psychoneuroimmunology: A personal view. Brain Behav Immun. 2007, 21: 34-44. 10.1016/j.bbi.2006.09.008.CrossRefPubMed
12.
go back to reference Elenkov IJ, Chrousos GP: Stress hormones, proinflammatory and anti-inflammatory cytokines, and autoimmunity. Ann N Y Acad Sci. 2002, 966: 290-303. 10.1111/j.1749-6632.2002.tb04229.x.CrossRefPubMed Elenkov IJ, Chrousos GP: Stress hormones, proinflammatory and anti-inflammatory cytokines, and autoimmunity. Ann N Y Acad Sci. 2002, 966: 290-303. 10.1111/j.1749-6632.2002.tb04229.x.CrossRefPubMed
13.
go back to reference Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP: Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation. 2005, 12: 255-269. 10.1159/000087104.CrossRefPubMed Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP: Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation. 2005, 12: 255-269. 10.1159/000087104.CrossRefPubMed
14.
go back to reference Ortega E, García JJ, Sáez MC, De la Fuente M: Changes with aging in the modulation of macrophages by norepinephrine. Mech Ageing Dev. 2000, 118: 103-114. 10.1016/S0047-6374(00)00160-3.CrossRefPubMed Ortega E, García JJ, Sáez MC, De la Fuente M: Changes with aging in the modulation of macrophages by norepinephrine. Mech Ageing Dev. 2000, 118: 103-114. 10.1016/S0047-6374(00)00160-3.CrossRefPubMed
15.
go back to reference García JJ, Sáez MC, De la Fuente M, Ortega E: Regulation of phagocytic process of macrophages by noradrenaline and its end metabolito 4-hydroxy-3-metoxyphenyl-glycol. Role of alpha- and beta-adrenoreceptors. Mol Cell Biochem. 2003, 254: 299-304. 10.1023/A:1027345820519.CrossRefPubMed García JJ, Sáez MC, De la Fuente M, Ortega E: Regulation of phagocytic process of macrophages by noradrenaline and its end metabolito 4-hydroxy-3-metoxyphenyl-glycol. Role of alpha- and beta-adrenoreceptors. Mol Cell Biochem. 2003, 254: 299-304. 10.1023/A:1027345820519.CrossRefPubMed
16.
go back to reference Sanders VM: Interdisciplinary research: Noradrenergic regulation of adaptive immunity. Brain, Behaviour and Immunity. 2006, 20: 1-8.CrossRef Sanders VM: Interdisciplinary research: Noradrenergic regulation of adaptive immunity. Brain, Behaviour and Immunity. 2006, 20: 1-8.CrossRef
17.
go back to reference Meltzer JC, MacNeil BJ, Sanders V, Pylypas S, Jansen AH, Greenberg AH, Nance DM: Stress-induced suppression of in vivo splenic cytokine production in the rat by neural and hormonal mechanisms. Brain Behav Immun. 2004, 18: 262-273. 10.1016/j.bbi.2003.09.003.CrossRefPubMed Meltzer JC, MacNeil BJ, Sanders V, Pylypas S, Jansen AH, Greenberg AH, Nance DM: Stress-induced suppression of in vivo splenic cytokine production in the rat by neural and hormonal mechanisms. Brain Behav Immun. 2004, 18: 262-273. 10.1016/j.bbi.2003.09.003.CrossRefPubMed
18.
go back to reference Nance DM, Sanders VM: Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun. 2007, 21: 736-745. 10.1016/j.bbi.2007.03.008.PubMedCentralCrossRefPubMed Nance DM, Sanders VM: Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun. 2007, 21: 736-745. 10.1016/j.bbi.2007.03.008.PubMedCentralCrossRefPubMed
19.
go back to reference Straznicky NE, Lambert EA, Nestel PJ, McGrane MT, Dawood T, Schlaich MP, Masuo K, Eikelis N, de Courten B, Mariani JA, Esler MD, Socratous F, Chopra R, Sari CI, Paul E, Lambert GW: Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes. 2010, 59: 71-79. 10.2337/db09-0934.PubMedCentralCrossRefPubMed Straznicky NE, Lambert EA, Nestel PJ, McGrane MT, Dawood T, Schlaich MP, Masuo K, Eikelis N, de Courten B, Mariani JA, Esler MD, Socratous F, Chopra R, Sari CI, Paul E, Lambert GW: Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes. 2010, 59: 71-79. 10.2337/db09-0934.PubMedCentralCrossRefPubMed
20.
go back to reference Straznicky NE, Lambert GW, Lambert EA: Neuroadrenergic dysfunction in obesity: an overview of the effects of weight loss. Curr Opin Lipidol. 2010, 21: 21-30. 10.1097/MOL.0b013e3283329c62.CrossRefPubMed Straznicky NE, Lambert GW, Lambert EA: Neuroadrenergic dysfunction in obesity: an overview of the effects of weight loss. Curr Opin Lipidol. 2010, 21: 21-30. 10.1097/MOL.0b013e3283329c62.CrossRefPubMed
21.
go back to reference Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS: A central role for JNK in obesity and insulin resistance. Nature. 2002, 420: 333-336. 10.1038/nature01137.CrossRefPubMed Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS: A central role for JNK in obesity and insulin resistance. Nature. 2002, 420: 333-336. 10.1038/nature01137.CrossRefPubMed
22.
go back to reference Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993, 259: 87-91. 10.1126/science.7678183.CrossRefPubMed Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993, 259: 87-91. 10.1126/science.7678183.CrossRefPubMed
23.
go back to reference Hotamisligil GS: Inflammation and metabolic disorders. Nature. 2006, 444: 860-867. 10.1038/nature05485.CrossRefPubMed Hotamisligil GS: Inflammation and metabolic disorders. Nature. 2006, 444: 860-867. 10.1038/nature05485.CrossRefPubMed
24.
go back to reference Pitsavos C, Panagiotakos DB, Chrysohoou C, Kavouras S, Stefanadis C: The associations between physical activity, inflammation, and coagulation markers, in people with metabolic syndrome: the ATTICA study. Eur J Cardiovasc Prev Rehabil. 2005, 12: 151-158. 10.1097/00149831-200504000-00010.PubMed Pitsavos C, Panagiotakos DB, Chrysohoou C, Kavouras S, Stefanadis C: The associations between physical activity, inflammation, and coagulation markers, in people with metabolic syndrome: the ATTICA study. Eur J Cardiovasc Prev Rehabil. 2005, 12: 151-158. 10.1097/00149831-200504000-00010.PubMed
25.
go back to reference Bassuk SS, Manson JE: Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol. 2005, 99: 1193-1204. 10.1152/japplphysiol.00160.2005.CrossRefPubMed Bassuk SS, Manson JE: Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol. 2005, 99: 1193-1204. 10.1152/japplphysiol.00160.2005.CrossRefPubMed
26.
go back to reference Pedersen BK: The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem. 2006, 42: 105-117.CrossRefPubMed Pedersen BK: The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem. 2006, 42: 105-117.CrossRefPubMed
27.
go back to reference Mathur N, Pedersen BK: Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm. Mathur N, Pedersen BK: Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm.
28.
go back to reference Ortega E: Neuroendocrine mediators in the modulation of phagocytosis by exercise: physiological implications. Exerc Immunol Rev. 2003, 9: 70-94.PubMed Ortega E: Neuroendocrine mediators in the modulation of phagocytosis by exercise: physiological implications. Exerc Immunol Rev. 2003, 9: 70-94.PubMed
29.
go back to reference Ortega E, Giraldo E, Hinchado MD, Martínez M, Ibáñez S, Cidoncha A, Collazos ME, García JJ: Role of Hsp72 and norepinephrine in the moderate exercise-induced stimulation of neutrophils' microbicide capacity. Eur J Appl Physiol. 2006, 98: 250-255. 10.1007/s00421-006-0269-7.CrossRefPubMed Ortega E, Giraldo E, Hinchado MD, Martínez M, Ibáñez S, Cidoncha A, Collazos ME, García JJ: Role of Hsp72 and norepinephrine in the moderate exercise-induced stimulation of neutrophils' microbicide capacity. Eur J Appl Physiol. 2006, 98: 250-255. 10.1007/s00421-006-0269-7.CrossRefPubMed
30.
go back to reference Ortega E, Giraldo E, Hinchado MD, Martín-Cordero L, García JJ: 72 kDa extracellular heat shock protein (eHsp72), norepinephrine (NE), and the innate immune response following moderate exercise. Heat Shock Proteins and Whole Body Physiology. Edited by: Asea A, Pedersen BK. 2010, USA: Springer, 329-350. Ortega E, Giraldo E, Hinchado MD, Martín-Cordero L, García JJ: 72 kDa extracellular heat shock protein (eHsp72), norepinephrine (NE), and the innate immune response following moderate exercise. Heat Shock Proteins and Whole Body Physiology. Edited by: Asea A, Pedersen BK. 2010, USA: Springer, 329-350.
31.
go back to reference Ortega E: Physiological and biochemistry: influence of exercise on phagocytosis. Int J Sports Med. 1994, 15: 5172-5178. Ortega E: Physiological and biochemistry: influence of exercise on phagocytosis. Int J Sports Med. 1994, 15: 5172-5178.
32.
go back to reference Medzhitov R: Origin and physiological roles of inflammation. Nature. 2008, 454: 428-435. 10.1038/nature07201.CrossRefPubMed Medzhitov R: Origin and physiological roles of inflammation. Nature. 2008, 454: 428-435. 10.1038/nature07201.CrossRefPubMed
33.
go back to reference Giraldo E, Garcia JJ, Hinchado MD, Ortega E: Exercise intensity-dependent changes in the inflammatory response in sedentary women: role of neuroendocrine parameters in the neutrophil phagocytic process and the pro-/anti-inflammatory cytokine balance. Neuroimmunomodulation. 2009, 16: 237-244. 10.1159/000212384.CrossRefPubMed Giraldo E, Garcia JJ, Hinchado MD, Ortega E: Exercise intensity-dependent changes in the inflammatory response in sedentary women: role of neuroendocrine parameters in the neutrophil phagocytic process and the pro-/anti-inflammatory cytokine balance. Neuroimmunomodulation. 2009, 16: 237-244. 10.1159/000212384.CrossRefPubMed
34.
go back to reference Plotkin BJ, Paulson D, Chelich A, Jurak D, Cole J, Kasimos J, Burdick JR, Casteel N: Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa/fa): susceptibility to Candida albicans infection and leucocyte function. J Med Microbiol. 1996, 44: 277-283. 10.1099/00222615-44-4-277.CrossRefPubMed Plotkin BJ, Paulson D, Chelich A, Jurak D, Cole J, Kasimos J, Burdick JR, Casteel N: Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa/fa): susceptibility to Candida albicans infection and leucocyte function. J Med Microbiol. 1996, 44: 277-283. 10.1099/00222615-44-4-277.CrossRefPubMed
35.
go back to reference Martin-Cordero L, Garcia JJ, Giraldo E, De la Fuente M, Manso R, Ortega E: Influence of exercise on the circulating levels and macrophage production of IL-1beta and IFNgamma affected by metabolic syndrome: an obese Zucker rat experimental animal model. Eur J Appl Physiol. 2009, 107: 535-543. 10.1007/s00421-009-1140-4.CrossRefPubMed Martin-Cordero L, Garcia JJ, Giraldo E, De la Fuente M, Manso R, Ortega E: Influence of exercise on the circulating levels and macrophage production of IL-1beta and IFNgamma affected by metabolic syndrome: an obese Zucker rat experimental animal model. Eur J Appl Physiol. 2009, 107: 535-543. 10.1007/s00421-009-1140-4.CrossRefPubMed
37.
go back to reference Elenkov IJ: Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int. 2008, 52: 40-51. 10.1016/j.neuint.2007.06.037.CrossRefPubMed Elenkov IJ: Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int. 2008, 52: 40-51. 10.1016/j.neuint.2007.06.037.CrossRefPubMed
38.
go back to reference Besedovsky H, del Rey A, Sorkin E, Dinarello CA: Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986, 233: 652-654. 10.1126/science.3014662.CrossRefPubMed Besedovsky H, del Rey A, Sorkin E, Dinarello CA: Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986, 233: 652-654. 10.1126/science.3014662.CrossRefPubMed
39.
go back to reference Mastorakos G, Pavlatou M, Diamanti-Kandarakis E, Chrousos GP: Exercise and the stress system. Hormones (Athens). 2005, 4: 73-89. Mastorakos G, Pavlatou M, Diamanti-Kandarakis E, Chrousos GP: Exercise and the stress system. Hormones (Athens). 2005, 4: 73-89.
40.
go back to reference Recasens M, Ricart W, Fernández-Real JM: Obesity and inflammation. Rev Med Univ Navarra. 2004, 48: 49-54.PubMed Recasens M, Ricart W, Fernández-Real JM: Obesity and inflammation. Rev Med Univ Navarra. 2004, 48: 49-54.PubMed
41.
go back to reference Steenberg A: The role of IL-6 in exercise-induced immune changes and metabolism. Exerc Immunol Rev. 2003, 9: 40-47. Steenberg A: The role of IL-6 in exercise-induced immune changes and metabolism. Exerc Immunol Rev. 2003, 9: 40-47.
42.
go back to reference Eder K, Baffy N, Falus A, Fulop AK: The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009, 58: 727-736. 10.1007/s00011-009-0060-4.CrossRefPubMed Eder K, Baffy N, Falus A, Fulop AK: The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009, 58: 727-736. 10.1007/s00011-009-0060-4.CrossRefPubMed
44.
go back to reference Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B: Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab. 2002, 87: 2084-2089. 10.1210/jc.87.5.2084.CrossRefPubMed Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B: Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab. 2002, 87: 2084-2089. 10.1210/jc.87.5.2084.CrossRefPubMed
45.
go back to reference Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO: Interleukin-6-deficient mice develop matureonset obesity. Nat Med. 2002, 8: 75-79. 10.1038/nm0102-75.CrossRefPubMed Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO: Interleukin-6-deficient mice develop matureonset obesity. Nat Med. 2002, 8: 75-79. 10.1038/nm0102-75.CrossRefPubMed
46.
go back to reference Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Møller K, Saltin B, Febbraio MA, Pedersen BK: Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab. 2003, 88: 3005-3010. 10.1210/jc.2002-021687.CrossRefPubMed Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Møller K, Saltin B, Febbraio MA, Pedersen BK: Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab. 2003, 88: 3005-3010. 10.1210/jc.2002-021687.CrossRefPubMed
47.
go back to reference Trujillo ME, Sullivan S, Harten I, Schneider SH, Greenberg AS, Fried SK: Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab. 2004, 89: 5577-5582. 10.1210/jc.2004-0603.CrossRefPubMed Trujillo ME, Sullivan S, Harten I, Schneider SH, Greenberg AS, Fried SK: Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab. 2004, 89: 5577-5582. 10.1210/jc.2004-0603.CrossRefPubMed
48.
go back to reference Petersen EW, Carey AL, Sacchetti M, Steinberg GR, Macaulay SL, Febbraio MA, Pedersen BK: Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol Endocrinol Metab. 2005, 288: 155-162.CrossRef Petersen EW, Carey AL, Sacchetti M, Steinberg GR, Macaulay SL, Febbraio MA, Pedersen BK: Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol Endocrinol Metab. 2005, 288: 155-162.CrossRef
49.
go back to reference Di Gregorio GB, Hensley L, Lu T, Ranganathan G, Kern PA: Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age related obesity. Am J Physiol Endocrinol Metab. 2004, 287: 182-187. 10.1152/ajpendo.00189.2003.CrossRef Di Gregorio GB, Hensley L, Lu T, Ranganathan G, Kern PA: Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age related obesity. Am J Physiol Endocrinol Metab. 2004, 287: 182-187. 10.1152/ajpendo.00189.2003.CrossRef
50.
go back to reference Kamimura D, Ishihara K, Hirano T: IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol. 2003, 149: 1-38.PubMed Kamimura D, Ishihara K, Hirano T: IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol. 2003, 149: 1-38.PubMed
51.
go back to reference Kristiansen OP, Mandrup-Poulsen T: Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes. 2005, 54 (Suppl 2): 114-124.CrossRef Kristiansen OP, Mandrup-Poulsen T: Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes. 2005, 54 (Suppl 2): 114-124.CrossRef
52.
go back to reference Barriga C, Martín MI, Ortega E, Rodriguez AB: Physiological concentrations of melatonin and corticosterone in stress and their relationship with phagocytic activity. J Neuroendocrinol. 2002, 14: 691-695. 10.1046/j.1365-2826.2002.00823.x.CrossRefPubMed Barriga C, Martín MI, Ortega E, Rodriguez AB: Physiological concentrations of melatonin and corticosterone in stress and their relationship with phagocytic activity. J Neuroendocrinol. 2002, 14: 691-695. 10.1046/j.1365-2826.2002.00823.x.CrossRefPubMed
53.
go back to reference Klimcakova E, Polak J, Moro C, Hejnova J, Majercik M, Viguerie N, Berlan M, Langin D, Stich V: Dynamic strength training improves insulin sensitivity without altering plasma levels and gene expression of adipokines in subcutaneous adipose tissue in obese men. J Clin Endocrinol Metab. 2006, 91: 5107-5112. 10.1210/jc.2006-0382.CrossRefPubMed Klimcakova E, Polak J, Moro C, Hejnova J, Majercik M, Viguerie N, Berlan M, Langin D, Stich V: Dynamic strength training improves insulin sensitivity without altering plasma levels and gene expression of adipokines in subcutaneous adipose tissue in obese men. J Clin Endocrinol Metab. 2006, 91: 5107-5112. 10.1210/jc.2006-0382.CrossRefPubMed
54.
go back to reference Roberts CK, Barnard RJ: Effects of exercise and diet on chronic disease. J Appl Physiol. 2005, 98: 3-30.CrossRefPubMed Roberts CK, Barnard RJ: Effects of exercise and diet on chronic disease. J Appl Physiol. 2005, 98: 3-30.CrossRefPubMed
55.
go back to reference Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND, Barnard RJ: Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol. 2006, 100: 1657-1665. 10.1152/japplphysiol.01292.2005.CrossRefPubMed Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND, Barnard RJ: Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol. 2006, 100: 1657-1665. 10.1152/japplphysiol.01292.2005.CrossRefPubMed
56.
go back to reference Xiang L, Naik J, Hester RL: Exercise-induced increase in skeletal muscle vasodilatory responses in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2005, 288: 987-991.CrossRef Xiang L, Naik J, Hester RL: Exercise-induced increase in skeletal muscle vasodilatory responses in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2005, 288: 987-991.CrossRef
57.
go back to reference Calabro P, Chang DW, Willerson JT, Yeh ET: Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol. 2005, 46: 1112-1113. 10.1016/j.jacc.2005.06.017.CrossRefPubMed Calabro P, Chang DW, Willerson JT, Yeh ET: Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol. 2005, 46: 1112-1113. 10.1016/j.jacc.2005.06.017.CrossRefPubMed
58.
go back to reference Ortega E, Giraldo E, Hinchado MD, Martín L, García JJ, De la Fuente M: Neuroimmunomodulation during exercise: role of catecholamines as "stress mediator" and/or "danger signal" for the innate immune response. Neuroimmunomodulation. 2007, 14: 206-212. 10.1159/000110648.CrossRefPubMed Ortega E, Giraldo E, Hinchado MD, Martín L, García JJ, De la Fuente M: Neuroimmunomodulation during exercise: role of catecholamines as "stress mediator" and/or "danger signal" for the innate immune response. Neuroimmunomodulation. 2007, 14: 206-212. 10.1159/000110648.CrossRefPubMed
59.
go back to reference Teixeira-Lemos E, Nunes S, Texeira F, Reis F: Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol. 2011, 10: 12-10.1186/1475-2840-10-12.PubMedCentralCrossRefPubMed Teixeira-Lemos E, Nunes S, Texeira F, Reis F: Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol. 2011, 10: 12-10.1186/1475-2840-10-12.PubMedCentralCrossRefPubMed
Metadata
Title
The interleukin-6 and noradrenaline mediated inflammation-stress feedback mechanism is dysregulated in metabolic syndrome: Effect of exercise
Authors
Leticia Martín-Cordero
Juan J García
Maria D Hinchado
Eduardo Ortega
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2011
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-10-42

Other articles of this Issue 1/2011

Cardiovascular Diabetology 1/2011 Go to the issue